TCL Archive Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival April 27, 2012
TCL Archive Senate Passes NIH Reauthorization 87-10; $2.5 Bil. Auhtority For NCI, New Line Items April 10, 1992